Two Types of Anti-TL (Thymus Leukemia) CTL Clones with Distinct Target Specificities: Differences in Cytotoxic Mechanisms and Accessory Molecule Requirements
Kunio Tsujimura(Hamamatsu University School of Medicine), Yuichi Obata(Nagoya University), Shigeru Iwase(Nagoya City University), Yasue Matsudaira(Aichi Cancer Center), Hideo Yagita∥(Juntendo University), Yoko Kaneko(Keio University)
Cited by 18
Related Papers
Tumor-infiltrating DCs suppress nucleic acid–mediated innate immune responses through interactions between the receptor TIM-3 and the alarmin HMGB1
|Nature Immunology|2012|832
NAK is an IκB kinase-activating kinase
|Nature|2000|374
Differential binding properties of B7-H1 and B7-DC to programmed death-1
|Biochemical and Biophysical Research Communications|2003|206
Antigen delivery targeted to tumor-associated macrophages overcomes tumor immune resistance
|Journal of Clinical Investigation|2019|143
The Novel Costimulatory Programmed Death Ligand 1/B7.1 Pathway Is Functional in Inhibiting Alloimmune Responses In Vivo
|The Journal of Immunology|2011|133